비글견을 이용한 GST 추출물의 단회 경구투여 용량증가 독성시험
A Single Oral Dose Toxicity Test of GST in Beagle Dogs
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: To provide information on the safety of GST (Gami-Sasangja-tang), we carried out a single oral dose-increasing toxicity test of GST in beagle dogs. Materials and Methods: Six beagle dogs (three males and three females) were randomly assigned to two groups (experimental group: n=4, control group: n=2). The experimental group (two males, two females) was given oral doses of GST in increasing order (1,250, 2,500, and 5,000 mg/kg) at three-day intervals. After administration, the participants’ mortality, clinical signs, and body weight changes were monitored for two weeks. After two weeks, all dogs were sacrificed for autopsy. Results: Temporary vomiting was observed according to increasing dosage (n=1, 250 mg/kg; n=4, 2,500 and 5,000 mg/kg). Transient diarrhea was observed on the second and third dosing day (n=1, 2,500 mg/kg; n=2, 5,000 mg/kg). Temporary salivation was noted on the third dosing day (n=3, 5,000 mg/kg). Compound-colored stool was observed in all dogs fed the GST on all dosing days and also on the following days. We found no mortality and no abnormalities in the clinical signs, body weight, and gross findings in any of the dogs tested. Conclusions: The maximum tolerated dose was over 5,000 mg/kg for both male and female dogs.
Abstract
Objectives: To provide information on the safety of GST (Gami-Sasangja-tang), we carried out a single oral dose-increasing toxicity test of GST in beagle dogs. Materials and Methods: Six beagle dogs (three males and three females) were randomly assigned to two groups (experimental group: n=4, control group: n=2). The experimental group (two males, two females) was given oral doses of GST in increasing order (1,250, 2,500, and 5,000 mg/kg) at three-day intervals. After administration, the participants’ mortality, clinical signs, and body weight changes were monitored for two weeks. After two weeks, all dogs were sacrificed for autopsy. Results: Temporary vomiting was observed according to increasing dosage (n=1, 250 mg/kg; n=4, 2,500 and 5,000 mg/kg). Transient diarrhea was observed on the second and third dosing day (n=1, 2,500 mg/kg; n=2, 5,000 mg/kg). Temporary salivation was noted on the third dosing day (n=3, 5,000 mg/kg). Compound-colored stool was observed in all dogs fed the GST on all dosing days and also on the following days. We found no mortality and no abnormalities in the clinical signs, body weight, and gross findings in any of the dogs tested. Conclusions: The maximum tolerated dose was over 5,000 mg/kg for both male and female dogs.
참고문헌 (24)
- Schultz-Larsen F, "Epidemiology of atopic dermatitis", Immunol Allergy Clin North Am, 22, pp.1~24 (2002)
- Hong SJ, "Korean ISAAC committee in Korean academy of pediatric allergy and respiratory disease", Pediatr Allergy Respir Dis(Korea), 17(Suppl 1), pp.S55~S66 (2007)
- Williams H, "International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups", J Allergy Clin Immunol, 121(4), pp.947~954 (2008)
- "국민건강보험 보도자료"[URL]
- 김진혜, "성인 아토피피부염 환자의 삶의 질", 대한피부과학회지, 49(11), pp.983~992 (2011), 대한피부과학회
- Watson W, "Atopic dermatitis", Allergy Asthma & Clinical Immunology, 7(Suppl 1), pp.S4~ (2011)
- 김태윤, "아토피피부염 치료의 최신 경향", Allergy Asthma & Respiratory Diseases, 19(3), pp.209~219 (2009), 대한 소아알레르기 호흡기학회
- 진실공, "외과정종", pp.244~ (1964), 인민위생출판사
- Gam BS, "Bon-Cho-Hak", pp.631~633 (1991), Younglimsa
- Park BK, "Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC", Nga murine model of atopic dermatitis, 2015, pp.165, 54~60
- 한종민, "GST의 Sprague-Dawley Rat를 이용한 단회 경구투여 독성시험 및 4주 반복 경구투여 용량결정시험", 대한한방내과학회지, 34(4), pp.349~361 (2013), 대한한방내과학회
- 김윤하, "GST 추출물의 Sprague-Dawley Rat를 이용한 13주 반복 경구투여 독성시험 및 4주 회복시험", 대한한방내과학회지, 35(3), pp.223~243 (2014), 대한한방내과학회
- 이철화, "GST 추출물의 유전독성평가", 동의생리병리학회지, 28(6), pp.621~629 (2014), 한의병리학회[DOI]
- Leung DY, "New insights into atopic dermatitis", J Clin Invest, 113, pp.651~657 (2004)
- Krakowski AC, "Management of atopic dermatitis in the pediatric population", Pediatrics, 122, pp.812~824 (2008)
- Nicol NH, "Successful strategies in atopic der-matitis management", Dermatol Nurs, (Suppl), pp.3~18 (2008)
- Hanifin JM, "Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)", American Academy of Dermatology Association “Administrative Regulations for Evidence-Based Clinical Practice Guidelines", 2004, pp.50, 391~404
- 박양, "한국에서 아토피피부염 진단과 치료의 임상적 실태 조사", Allergy Asthma & Respiratory Diseases, 1(3), pp.257~265 (2013), 대한 소아알레르기 호흡기학회
- 윤영희, "아토피피부염의 한의학 진료 지침 개발을 위한 사전 연구", 한방안이비인후피부과학회지, 25(2), pp.38~48 (2012), 대한한방안이비인후피부과학회[DOI]
- 식품의약품안전처, "식품의약품안전처고시 제2015-82호 (2015년 11월 11일) 의약품등의 독성시험기준", ~ (2015)
- Ha CS, "A study of hematology and serum chemistry in beagle dogs", Korean J Lab Ani Sci, 11(2), pp.153~158 (1995)
- 양혜진, "비글견을 이용한 phlorotannin의 단회 경구투여 독성시험", 한국수산과학회지, 47(4), pp.356~362 (2014), 한국수산과학회
- 김종대, "백부근이 흰쥐의 간 및 신장에미치는 조직학적 연구", 대한한의학회지, 20(2), pp.45~53 (1999)
- 이제헌, "백부근의 독성에 관한문헌적 고찰", 제한동의학술원논문집, 8(1), pp.23~32 (2010)